Compare ZLAB & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | AGM |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | China | United States |
| Employees | N/A | 212 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.6B |
| IPO Year | 2017 | N/A |
| Metric | ZLAB | AGM |
|---|---|---|
| Price | $18.09 | $171.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $49.60 | ★ $215.00 |
| AVG Volume (30 Days) | ★ 656.8K | 80.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $25.97 |
| Revenue Next Year | $26.03 | $12.21 |
| P/E Ratio | ★ N/A | $9.95 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $136.57 |
| 52 Week High | $44.34 | $210.64 |
| Indicator | ZLAB | AGM |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 52.36 |
| Support Level | $16.88 | $167.06 |
| Resistance Level | $19.64 | $177.14 |
| Average True Range (ATR) | 0.97 | 5.30 |
| MACD | -0.31 | -1.18 |
| Stochastic Oscillator | 5.19 | 23.69 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven reportable segments: Farm & Ranch, which generates maximum revenue, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA. Geographically, the company's operations are spread across different regions in the United States.